Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies
Whistler, BC, Canada
Organiser: Other
Attendance type(s): Hybrid
Event Dates: 08—11 Jun 2025
- 08/06/2025
- 09/06/2025
- 10/06/2025
- 11/06/2025
Registration Deadline: 7 Jun 2025
Neurodegenerative diseases are common but largely untreatable, despite massive investments from both academic and industry sectors. Tackling these diseases will require a collective and integrated effort to address the challenges of identifying, understanding, and translating cellular mechanisms of neurodegeneration into effective therapies.
This meeting will take an innovative approach by assembling speakers and attendees across diverse fields, creating synergy between geneticists, cell biologists, computational biologists, clinicians, and patients to broaden, deepen and integrate our understanding of these diseases. These experts will illustrate how genomics, technology, computational advances, and a focus on convergent cellular pathways will drive innovation and discovery in the field, irrespective of entrenched models. The program will feature new voices in the field, who will generate discussion around new and innovative ideas and directions.
We anticipate that attendees will leave this meeting with a deeper appreciation of how genetic discoveries inform and inspire mechanistic inquiries about cellular disease mechanisms, and how new discoveries and new technologies are driving a revolution in how neurodegenerative diseases are classified and treated.
This conference will be held jointly with the Keystone Symposium on Neuroimmune Interactions: A Systems-Wide Perspective on Whole Organism Physiology to spark innovative cross-disciplinary insights and collaborations towards understanding neuroimmune drivers of neurodegenerative disease and identifying novel therapeutic targets.
Contact Details
Name: Keystone Symposia
Phone: 18002530685
Email: comms@keystonesymposia.org